AstraZeneca: all 4,196 studies
Page 39 of 42. Open to participants first (299), then studies with results posted, then the rest; newest registration first within each.
- Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid TumoursCompletedNCT00475956Phase 1
- Phase 1 Pharmacokinetics of Intravenous Nexium in ChildrenCompletedNCT00474019Phase 1
- Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and IrinotecanTerminatedNCT00473616Phase 1
- A Multicenter Study to Evaluate the Safety and Tolerability of Single-Dose for MEDI-545CompletedNCT00472758Phase 1
- Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD4877TerminatedNCT00471367Phase 1
- AZD6244 (ARRY-142886) Solid Oral Dosage Formulation in Participants With Advanced Solid MalignanciesActive, not recruitingNCT00463814Phase 1
- Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic MalignanciesTerminatedNCT00460460Phase 1
- Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective DisorderTerminatedNCT00457899Phase 3
- AZD8330 First Time in Man in Patients With Advanced MalignanciesCompletedNCT00454090Phase 1
- A Two-week Study Assessing the Onset of Effect Questionnaire (OEQ) Administered Daily Versus Weekly in Adult SubjectsCompletedNCT00449527Phase 3
- A Two-week Study Assessing the Onset of Effect Questionnaire Administered Pre-dose Versus Post-dose in Adult SubjectsCompletedNCT00449501Phase 3
- Dose Finding of Quetiapine Fumarate 200mg vs 400mg in First Episode PsychosisCompletedNCT00449397Phase 3
- Efficacy and Safety of Seroquel and Lithium as Monotherapy in Acute Mania Treatment in Bipolar Disorder PatientsCompletedNCT00448578Phase 3
- Exploratory Study to Evaluate Various Pharmacodynamic Effects of Subcutaneously Infused or Injected Pramlintide in Obese SubjectsCompletedNCT00444561Phase 2
- The Paroxysmal Nocturnal Hemoglobinuria Early Access Treatment ProtocolApproved for marketingNCT00438789
- Clinical Trial to Assess Rate of Onset of Bronchodilator Action in Severe Stable Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00435760Phase 3
- Study to Compare Two Formulations of CP-675,206 Monoclonal AntibodyCompletedNCT00431275Phase 1
- Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease. Ratio-Study. (BY217/M2-112)CompletedNCT00430729Phase 3
- An Open-label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving NexiumCompletedNCT00428701Phase 4
- Study of Efficacy and Safety of Seroquel (Quetiapine Fumarate) as Mono-Therapy for Acute SchizophrenicCompletedNCT00428350Phase 4
- Phase III/Seroquel SR Bipolar Depression Monotherapy - USCompletedNCT00422214Phase 3
- Phase 3 /Seroquel SR Acute Mania Monotherapy - USCompletedNCT00422123Phase 3
- Efficacy and Safety Study of Symbicort Turbuhaler in Chinese Patients With COPDCompletedNCT00421122Phase 3
- Study to Assess Safety of AZD7762 Administered Alone and in Combination With Gemcitabine in Patients With Advanced Solid MalignanciesCompletedNCT00413686Phase 1
- Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERDCompletedNCT00410592Phase 4
- Efficacy and Safety Study of Esomeprazole vs Omeprazole to Treat Acute Non-Variceal Upper Gastrointestinal BleedingCompletedNCT00402259Phase 3
- A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese SubjectsCompletedNCT00402077Phase 2
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ACH-0137171 in Participants With Chronic Hepatitis C InfectionTerminatedNCT00401947Phase 2
- ORBITAL: Open-Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement Of LDL GoalsWithdrawnNCT00396240Phase 4
- Evaluation of the Efficacy of Rosuvastatin in Daily Practice (TARGET)CompletedNCT00396110
- Examine National Characteristics & Outcome Measures of GERD Patients Using the PPI Acid Suppression Symptom (PASS) Test for ResponseCompletedNCT00392002Phase 4
- Phase I, Open-Label, Dose-Escalation Study of AZD4877 in Solid TumorsCompletedNCT00389389Phase 1
- PPI Sequencing StudyCompletedNCT00384592Phase 4
- A Study of Ciclesonide Nasal Spray in Patients 18 Years and Older With Seasonal Allergic Rhinitis (BY9010/M1-413)CompletedNCT00384475Phase 3
- Study to Evaluate the Incidence of Hospitalizations and Respiratory Tract Infections in Premature InfantsCompletedNCT00384462
- Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mgCompletedNCT00383929Phase 3
- A Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 DiabetesCompletedNCT00382239Phase 2
- Safety and Efficacy of Exenatide as MonotherapyCompletedNCT00381342Phase 3
- Open-Label, 48-Week Extension Study of Elvucitabine in Combination With Background Antiretroviral Therapy (ART) for Participants Who Have Completed Study ACH443-014ACompletedNCT00380159Phase 2
- Rosuvastatin ORBITAL GermanyCompletedNCT00379249Phase 3
- Airway Clearance StudyCompletedNCT00379028Phase 4
- AZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine TherapyCompletedNCT00372944Phase 2
- Dose-Finding Study Of CP-675,206 And SU011248 In Patients With Metastatic Renal Cell CarcinomaCompletedNCT00372853Phase 1
- AZD6244 Versus Pemetrexed (Alimta®) in Patients With Non-small Cell Lung Cancer, Who Have Failed One or Two Prior Chemotherapy RegimenCompletedNCT00372788Phase 2
- An Epidemiological Study to Evaluate the RSV-Associated Lower Respiratory Track in Infections in InfantsCompletedNCT00369759
- Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients With Type 2 DiabetesCompletedNCT00359879Phase 3
- Ropivacaine Versus Bupivacaine for Spinal Anaesthesia in Patients Undergoing Unilateral Lower Limb SurgeryCompletedNCT00358280Phase 3
- An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus PatientsCompletedNCT00352261Phase 4
- Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive DisorderCompletedNCT00351910Phase 3
- Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive DisorderCompletedNCT00351169Phase 3
- Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular EventCompletedNCT00347217
- Study to Evaluate the Safety of MEDI-534 Vaccine Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3) in Healthy ChildrenCompletedNCT00345670Phase 1
- Symptom Adapted Therapy in GERD PatientsCompletedNCT00343161Phase 4
- AZD1152 in Patients With Advanced Solid MalignanciesCompletedNCT00338182Phase 1
- Randomised Study to Compare the Efficacy of AZD6244 vs TMZCompletedNCT00338130Phase 2
- Korean Rosuvastatin Effectiveness Study in Nondiabetic Metabolic SyndromeCompletedNCT00335699Phase 4
- Phase II Iressa + Irradiation Followed by Chemo in NSCLCCompletedNCT00333294Phase 2
- Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety DisorderCompletedNCT00329446Phase 3
- Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety DisorderCompletedNCT00329264Phase 3
- PULSAR - A Prospective Study to Evaluate the Utility of Low Doses of the Statins Atorvastatin and Rosuvastatin.CompletedNCT00329173Phase 3
- Seroquel STACK Study in Schizophrenic or Schizoaffective SubjectsCompletedNCT00328978Phase 3
- Faslodex 500mg Multiple Dose Tolerability Study in BC PatientsCompletedNCT00328120Phase 1
- Faslodex Advanced Breast Cancer Local Chinese StudyCompletedNCT00327769Phase 3
- Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive DisordersCompletedNCT00326144Phase 3
- Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive DisordersCompletedNCT00326105Phase 3
- Prevention of Asthma Relapse After Discharge From EmergencyCompletedNCT00326053Phase 3
- Study To Evaluate the Safety of Bivalent VaccineCompletedNCT00325481Phase 3
- Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and MetforminCompletedNCT00324363Phase 3
- Efficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety DisorderCompletedNCT00322595Phase 3
- Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive DisorderCompletedNCT00321490Phase 3
- Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive DisorderCompletedNCT00320268Phase 3
- Combination Casodex® and Iressa™ in Locally Advanced Prostate CancerCompletedNCT00319787Phase 2
- Combination Weekly Taxotere™ With Iressa™ /Placebo in Metastatic Breast CancerCompletedNCT00319618Phase 2
- Real Life Effectiveness in Asthma of Symbicort Single Inhaler TherapyCompletedNCT00319306Phase 3
- Nexium RESPONSE TrialCompletedNCT00318968Phase 4
- Addition of Quetiapine in Obsessive Compulsive Disorder - Westenberg StudyCompletedNCT00318539Phase 2
- PPI Test in GP PatientsCompletedNCT00318084Phase 4
- Phase I Study of ZD4054 (Zibotentan) and Docetaxel in Patients With Metastatic HRPCCompletedNCT00314782Phase 1
- Safety and Tolerability of Ciclesonide and Formoterol Fumarate Inhaled Once Daily in Patients With Asthma (18 to 75 y) (BY9010/M1-506)CompletedNCT00314509Phase 2
- Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients.CompletedNCT00314210Phase 3
- Quetiapine Fumarate Bipolar Maintenance MonotherapyCompletedNCT00314184Phase 3
- Study of Ticilimumab in Patients With Metastatic Colorectal Cancer Whose Disease Had Progressed After TreatmentCompletedNCT00313794Phase 2
- A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes MellitusCompletedNCT00313183Phase 2
- Randomized Study Of CP-675,206 or Best Supportive Care Immediately After Platinum-Based Therapy For Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00312975Phase 2
- Study of Once Daily Elvucitabine Versus Lamivudine in Participants With a Documented M184V MutationCompletedNCT00312039Phase 1/2
- Use of Quetiapine as an Add on Therapy in the Treatment of Post Traumatic Stress DisorderCompletedNCT00306540Phase 3
- Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417)CompletedNCT00305487Phase 3
- Effect of Ciclesonide on Quality of Life in Patients With Moderate Persistent Asthma (21 to 65 y) (BY9010/AR-101)CompletedNCT00305461Phase 3
- Effect of Quetiapine on Negative Symptoms and CognitionCompletedNCT00305422Phase 3
- Fast Titration in the Treatment of Schizophrenia, TaiwanCompletedNCT00304473Phase 3
- Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal PatientsCompletedNCT00303524Phase 2
- Efficacy of Quetiapine in Generalised Social Anxiety DisorderTerminatedNCT00302770Phase 3
- 3 Years of Anastrozole vs. no Treatment as Extended Adjuvant Therapy for Postmenopausal Women With Breast CancerCompletedNCT00300508Phase 3
- GALLEX 4 - Long-Term Extension Study to Evaluate Tesaglitazar Therapy in Patients With Type 2 DiabetesTerminatedNCT00300105Phase 3
- Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE)CompletedNCT00299819Phase 1
- A Study of IRESSA in Relapsed and Refractory Small Cell Lung CancerCompletedNCT00298688Phase 2
- Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary SyndromeCompletedNCT00296387Phase 3
- ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.CompletedNCT00291759Phase 3
- Validation of RDQ QuestionnaireCompletedNCT00291746Phase 4
- SALTO - Symbicort Single Inhaler Therapy Use in Adolescent Adults and Adults With Persistent AsthmaCompletedNCT00290264Phase 3